

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 8.36921058 |
| 2 | regulation of guanylate cyclase activity (GO:0031282) | 7.91477987 |
| 3 | drug transmembrane transport (GO:0006855) | 7.87243435 |
| 4 | angiotensin maturation (GO:0002003) | 7.76475155 |
| 5 | epoxygenase P450 pathway (GO:0019373) | 7.45959460 |
| 6 | drug catabolic process (GO:0042737) | 7.32482223 |
| 7 | drug transport (GO:0015893) | 7.26565260 |
| 8 | intestinal cholesterol absorption (GO:0030299) | 7.26049507 |
| 9 | urate metabolic process (GO:0046415) | 7.09797344 |
| 10 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.75895195 |
| 11 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.30147552 |
| 12 | lysine metabolic process (GO:0006553) | 6.16622929 |
| 13 | lysine catabolic process (GO:0006554) | 6.16622929 |
| 14 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.99022616 |
| 15 | organic cation transport (GO:0015695) | 5.72920544 |
| 16 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.50392877 |
| 17 | phosphate ion transport (GO:0006817) | 5.50324119 |
| 18 | exogenous drug catabolic process (GO:0042738) | 5.36268537 |
| 19 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.31647037 |
| 20 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.31647037 |
| 21 | endocrine process (GO:0050886) | 5.31647037 |
| 22 | flavonoid metabolic process (GO:0009812) | 5.16097058 |
| 23 | renal absorption (GO:0070293) | 5.14045375 |
| 24 | cysteine metabolic process (GO:0006534) | 4.96975997 |
| 25 | adhesion of symbiont to host cell (GO:0044650) | 4.92654558 |
| 26 | virion attachment to host cell (GO:0019062) | 4.92654558 |
| 27 | * modified amino acid transport (GO:0072337) | 4.88105131 |
| 28 | cellular glucuronidation (GO:0052695) | 4.84218274 |
| 29 | peptide catabolic process (GO:0043171) | 4.82197157 |
| 30 | uronic acid metabolic process (GO:0006063) | 4.81707709 |
| 31 | glucuronate metabolic process (GO:0019585) | 4.81707709 |
| 32 | regulation of cGMP biosynthetic process (GO:0030826) | 4.81088365 |
| 33 | regulation of systemic arterial blood pressure (GO:0003073) | 4.80521979 |
| 34 | excretion (GO:0007588) | 4.79751445 |
| 35 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.78181570 |
| 36 | vitamin D metabolic process (GO:0042359) | 4.76909018 |
| 37 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.73138056 |
| 38 | phosphate ion transmembrane transport (GO:0035435) | 4.72333135 |
| 39 | quaternary ammonium group transport (GO:0015697) | 4.72146275 |
| 40 | bile acid and bile salt transport (GO:0015721) | 4.70971728 |
| 41 | actin filament depolymerization (GO:0030042) | 4.68291950 |
| 42 | homocysteine metabolic process (GO:0050667) | 4.63661394 |
| 43 | peptide hormone processing (GO:0016486) | 4.59257448 |
| 44 | regulation of cellular extravasation (GO:0002691) | 4.56815629 |
| 45 | glutathione biosynthetic process (GO:0006750) | 4.48505914 |
| 46 | alkaloid metabolic process (GO:0009820) | 4.45153057 |
| 47 | regulation of bile acid biosynthetic process (GO:0070857) | 4.41186200 |
| 48 | oligosaccharide catabolic process (GO:0009313) | 4.37779853 |
| 49 | fructose metabolic process (GO:0006000) | 4.35317310 |
| 50 | polyol transport (GO:0015791) | 4.33451999 |
| 51 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.32480944 |
| 52 | vitamin A metabolic process (GO:0006776) | 4.29004843 |
| 53 | trivalent inorganic anion homeostasis (GO:0072506) | 4.21847624 |
| 54 | phosphate ion homeostasis (GO:0055062) | 4.21847624 |
| 55 | glyoxylate metabolic process (GO:0046487) | 4.20462723 |
| 56 | NADH metabolic process (GO:0006734) | 4.18359851 |
| 57 | response to phenylpropanoid (GO:0080184) | 4.15910262 |
| 58 | urea cycle (GO:0000050) | 4.09644143 |
| 59 | drinking behavior (GO:0042756) | 4.09628305 |
| 60 | urea metabolic process (GO:0019627) | 4.07436615 |
| 61 | regulation of cGMP metabolic process (GO:0030823) | 4.06053200 |
| 62 | arginine metabolic process (GO:0006525) | 4.04601780 |
| 63 | response to mercury ion (GO:0046689) | 4.04410567 |
| 64 | transepithelial transport (GO:0070633) | 4.00112744 |
| 65 | vitamin transport (GO:0051180) | 3.99893161 |
| 66 | sulfate transmembrane transport (GO:1902358) | 3.99541198 |
| 67 | aspartate family amino acid catabolic process (GO:0009068) | 3.97990207 |
| 68 | adhesion of symbiont to host (GO:0044406) | 3.97893118 |
| 69 | vitamin biosynthetic process (GO:0009110) | 3.93383919 |
| 70 | vitamin transmembrane transport (GO:0035461) | 3.92817069 |
| 71 | tricarboxylic acid metabolic process (GO:0072350) | 3.92698802 |
| 72 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.87643501 |
| 73 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.87643501 |
| 74 | renal system process involved in regulation of blood volume (GO:0001977) | 3.85541444 |
| 75 | carnitine transport (GO:0015879) | 3.85095362 |
| 76 | amino-acid betaine transport (GO:0015838) | 3.85095362 |
| 77 | cellular response to nitric oxide (GO:0071732) | 3.81748345 |
| 78 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.78535103 |
| 79 | short-chain fatty acid metabolic process (GO:0046459) | 3.78378816 |
| 80 | nitrogen cycle metabolic process (GO:0071941) | 3.76006562 |
| 81 | bile acid metabolic process (GO:0008206) | 3.74700131 |
| 82 | drug metabolic process (GO:0017144) | 3.72127116 |
| 83 | glucose 6-phosphate metabolic process (GO:0051156) | 3.71650831 |
| 84 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.71422891 |
| 85 | lipoprotein metabolic process (GO:0042157) | 3.69418693 |
| 86 | protein-lipid complex assembly (GO:0065005) | 3.68981416 |
| 87 | peptide biosynthetic process (GO:0043043) | 3.68854007 |
| 88 | diacylglycerol metabolic process (GO:0046339) | 3.65298409 |
| 89 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.65253676 |
| 90 | toxin transport (GO:1901998) | 3.60514970 |
| 91 | regulation of cholesterol homeostasis (GO:2000188) | 3.58074549 |
| 92 | cytidine deamination (GO:0009972) | 3.56319316 |
| 93 | cytidine metabolic process (GO:0046087) | 3.56319316 |
| 94 | cytidine catabolic process (GO:0006216) | 3.56319316 |
| 95 | digestive system process (GO:0022600) | 3.54786665 |
| 96 | * sulfur compound transport (GO:0072348) | 3.53806093 |
| 97 | proline metabolic process (GO:0006560) | 3.53479227 |
| 98 | glycolipid catabolic process (GO:0019377) | 3.52144170 |
| 99 | lipoprotein transport (GO:0042953) | 3.51630151 |
| 100 | glycerol metabolic process (GO:0006071) | 3.49775902 |
| 101 | alditol metabolic process (GO:0019400) | 3.49543841 |
| 102 | hormone catabolic process (GO:0042447) | 3.47111590 |
| 103 | amino-acid betaine metabolic process (GO:0006577) | 3.46885612 |
| 104 | hydrogen peroxide catabolic process (GO:0042744) | 3.45339267 |
| 105 | cellular carbohydrate catabolic process (GO:0044275) | 3.45232070 |
| 106 | regulation of vitamin metabolic process (GO:0030656) | 3.44848330 |
| 107 | bicarbonate transport (GO:0015701) | 3.43904906 |
| 108 | quinone biosynthetic process (GO:1901663) | 3.43889120 |
| 109 | glycosphingolipid catabolic process (GO:0046479) | 3.43271742 |
| 110 | glutathione derivative biosynthetic process (GO:1901687) | 3.42470110 |
| 111 | glutathione derivative metabolic process (GO:1901685) | 3.42470110 |
| 112 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.41568578 |
| 113 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.40091229 |
| 114 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.40091229 |
| 115 | high-density lipoprotein particle remodeling (GO:0034375) | 3.37369995 |
| 116 | antibacterial humoral response (GO:0019731) | 3.37366048 |
| 117 | fatty acid beta-oxidation (GO:0006635) | 3.33576413 |
| 118 | negative regulation of cholesterol transport (GO:0032375) | 3.32582809 |
| 119 | negative regulation of sterol transport (GO:0032372) | 3.32582809 |
| 120 | response to nitric oxide (GO:0071731) | 3.31470979 |
| 121 | carnitine metabolic process (GO:0009437) | 3.31144646 |
| 122 | omega-hydroxylase P450 pathway (GO:0097267) | 3.31074950 |
| 123 | cobalamin metabolic process (GO:0009235) | 3.30613695 |
| 124 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.30038158 |
| 125 | glutathione metabolic process (GO:0006749) | 3.28968489 |
| 126 | cellular modified amino acid catabolic process (GO:0042219) | 3.27751447 |
| 127 | sulfate transport (GO:0008272) | 3.27595792 |
| 128 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.25561374 |
| 129 | sphingomyelin metabolic process (GO:0006684) | 3.25363353 |
| 130 | heme transport (GO:0015886) | 3.24921078 |
| 131 | antimicrobial humoral response (GO:0019730) | 3.24383398 |
| 132 | L-ascorbic acid metabolic process (GO:0019852) | 3.23889558 |
| 133 | regulation of triglyceride catabolic process (GO:0010896) | 3.22455917 |
| 134 | cGMP biosynthetic process (GO:0006182) | 3.20983253 |
| 135 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.18389974 |
| 136 | positive regulation of pseudopodium assembly (GO:0031274) | 3.18234304 |
| 137 | response to hepatocyte growth factor (GO:0035728) | 3.18217861 |
| 138 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.18217861 |
| 139 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.17691398 |
| 140 | negative regulation of digestive system process (GO:0060457) | 3.17098527 |
| 141 | beta-amyloid metabolic process (GO:0050435) | 3.16313335 |
| 142 | digestion (GO:0007586) | 3.16235816 |
| 143 | protein-lipid complex remodeling (GO:0034368) | 3.15784963 |
| 144 | macromolecular complex remodeling (GO:0034367) | 3.15784963 |
| 145 | plasma lipoprotein particle remodeling (GO:0034369) | 3.15784963 |
| 146 | response to hydroperoxide (GO:0033194) | 3.14861663 |
| 147 | sterol homeostasis (GO:0055092) | 3.14547028 |
| 148 | glycosylceramide metabolic process (GO:0006677) | 3.12720946 |
| 149 | regulation of cholesterol esterification (GO:0010872) | 3.12059753 |
| 150 | mRNA modification (GO:0016556) | 3.10682805 |
| 151 | fat-soluble vitamin metabolic process (GO:0006775) | 3.10249318 |
| 152 | 2-oxoglutarate metabolic process (GO:0006103) | 3.10193243 |
| 153 | positive regulation of cGMP metabolic process (GO:0030825) | 3.09974545 |
| 154 | positive regulation of lipid catabolic process (GO:0050996) | 3.09743177 |
| 155 | metanephric tubule development (GO:0072170) | 3.09065945 |
| 156 | metanephric nephron tubule development (GO:0072234) | 3.09065945 |
| 157 | plasma lipoprotein particle assembly (GO:0034377) | 3.08539102 |
| 158 | phospholipid efflux (GO:0033700) | 3.07252263 |
| 159 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.07094960 |
| 160 | cholesterol homeostasis (GO:0042632) | 3.06932889 |
| 161 | sodium ion transport (GO:0006814) | 3.06051770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.39068620 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.90657636 |
| 3 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.61590962 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.89704948 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.79591664 |
| 6 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.41274485 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.37171789 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.32933559 |
| 9 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.04694982 |
| 10 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.80836589 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.80645392 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.75722013 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.72903648 |
| 14 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.43766570 |
| 15 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.41830175 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.36099565 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.35849784 |
| 18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.34480048 |
| 19 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.10561602 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.97599408 |
| 21 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.97120440 |
| 22 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.90955336 |
| 23 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.89530155 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.87907333 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.87091465 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.80283052 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.79780801 |
| 28 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.77937403 |
| 29 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.76421485 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.67832295 |
| 31 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.66601964 |
| 32 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.64208165 |
| 33 | VDR_22108803_ChIP-Seq_LS180_Human | 1.55786701 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.53697662 |
| 35 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.53648080 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48503679 |
| 37 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.45546990 |
| 38 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.44186349 |
| 39 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.43066280 |
| 40 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.43028855 |
| 41 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40101095 |
| 42 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.37565061 |
| 43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.34857528 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.34661279 |
| 45 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.34484425 |
| 46 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33982690 |
| 47 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.33977603 |
| 48 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.33898375 |
| 49 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.33314766 |
| 50 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.32206335 |
| 51 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.31590439 |
| 52 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.28864982 |
| 53 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28112158 |
| 54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27932605 |
| 55 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27374373 |
| 56 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.27240049 |
| 57 | GATA2_19941826_ChIP-Seq_K562_Human | 1.26775323 |
| 58 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26770768 |
| 59 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24929445 |
| 60 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.24515209 |
| 61 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.23523002 |
| 62 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23085557 |
| 63 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.20289221 |
| 64 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.19675604 |
| 65 | NCOR_22424771_ChIP-Seq_293T_Human | 1.19448104 |
| 66 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18689781 |
| 67 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.18577726 |
| 68 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.17623598 |
| 69 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.17367616 |
| 70 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.17151452 |
| 71 | ATF3_27146783_Chip-Seq_COLON_Human | 1.16651912 |
| 72 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16470131 |
| 73 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15216064 |
| 74 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.14483327 |
| 75 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.14483327 |
| 76 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.13152958 |
| 77 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.12932710 |
| 78 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.11445799 |
| 79 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.11191543 |
| 80 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.10127758 |
| 81 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.09964016 |
| 82 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.09916355 |
| 83 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.09081311 |
| 84 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08705752 |
| 85 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07952983 |
| 86 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.07063311 |
| 87 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05232291 |
| 88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05113230 |
| 89 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04244958 |
| 90 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.02895041 |
| 91 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.01447675 |
| 92 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.01444467 |
| 93 | * MYC_19829295_ChIP-Seq_ESCs_Human | 1.01164898 |
| 94 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00316921 |
| 95 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.99146902 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98399321 |
| 97 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.97896113 |
| 98 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97869891 |
| 99 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97715927 |
| 100 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.96825775 |
| 101 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.92004691 |
| 102 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.90574163 |
| 103 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89589106 |
| 104 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88999670 |
| 105 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.88839662 |
| 106 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.87945590 |
| 107 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86563808 |
| 108 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86552920 |
| 109 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.85444633 |
| 110 | SA1_27219007_Chip-Seq_Bcells_Human | 0.85146893 |
| 111 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.84358311 |
| 112 | CBP_21632823_ChIP-Seq_H3396_Human | 0.83614789 |
| 113 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.83582585 |
| 114 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.83582585 |
| 115 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.83435907 |
| 116 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.83262399 |
| 117 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83171998 |
| 118 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.82945835 |
| 119 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82558002 |
| 120 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.82412603 |
| 121 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82179016 |
| 122 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.82089142 |
| 123 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.81904410 |
| 124 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.81286580 |
| 125 | P300_19829295_ChIP-Seq_ESCs_Human | 0.80965198 |
| 126 | RXR_22108803_ChIP-Seq_LS180_Human | 0.80364737 |
| 127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.80362362 |
| 128 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.80295132 |
| 129 | NFYA_21822215_ChIP-Seq_K562_Human | 0.79981632 |
| 130 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.79797663 |
| 131 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.79612829 |
| 132 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.79039783 |
| 133 | P68_20966046_ChIP-Seq_HELA_Human | 0.78874389 |
| 134 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.78752041 |
| 135 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.78720168 |
| 136 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.78670542 |
| 137 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.78540567 |
| 138 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78266596 |
| 139 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78023149 |
| 140 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.77981416 |
| 141 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.76826642 |
| 142 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76818180 |
| 143 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.76610560 |
| 144 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76565636 |
| 145 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.76458009 |
| 146 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.76443134 |
| 147 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.76138477 |
| 148 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.75984116 |
| 149 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.75233366 |
| 150 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.74890560 |
| 151 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.74821776 |
| 152 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.74479596 |
| 153 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.73882264 |
| 154 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.73797496 |
| 155 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.73664686 |
| 156 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.73562990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005360_urolithiasis | 7.60128308 |
| 2 | MP0004043_abnormal_pH_regulation | 5.00231934 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.79807743 |
| 4 | MP0004019_abnormal_vitamin_homeostasis | 4.50632881 |
| 5 | MP0001666_abnormal_nutrient_absorption | 4.48679376 |
| 6 | MP0003252_abnormal_bile_duct | 3.47484682 |
| 7 | * MP0005332_abnormal_amino_acid | 3.41221145 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.27347066 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 3.26709697 |
| 10 | MP0003878_abnormal_ear_physiology | 3.25895164 |
| 11 | MP0005377_hearing/vestibular/ear_phenot | 3.25895164 |
| 12 | MP0004264_abnormal_extraembryonic_tissu | 3.24249889 |
| 13 | MP0009379_abnormal_foot_pigmentation | 3.21841461 |
| 14 | * MP0009643_abnormal_urine_homeostasis | 3.03305341 |
| 15 | MP0001765_abnormal_ion_homeostasis | 2.79366230 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 2.70344979 |
| 17 | MP0009840_abnormal_foam_cell | 2.69796852 |
| 18 | MP0005365_abnormal_bile_salt | 2.60396830 |
| 19 | MP0003183_abnormal_peptide_metabolism | 2.59569527 |
| 20 | MP0005636_abnormal_mineral_homeostasis | 2.33249693 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.19821933 |
| 22 | MP0005084_abnormal_gallbladder_morpholo | 2.16680400 |
| 23 | MP0004147_increased_porphyrin_level | 2.13822426 |
| 24 | * MP0002136_abnormal_kidney_physiology | 2.13585785 |
| 25 | MP0003195_calcinosis | 2.13104002 |
| 26 | MP0001756_abnormal_urination | 2.12108858 |
| 27 | MP0010329_abnormal_lipoprotein_level | 2.08071606 |
| 28 | MP0003868_abnormal_feces_composition | 2.07171423 |
| 29 | MP0000462_abnormal_digestive_system | 1.68146255 |
| 30 | MP0005409_darkened_coat_color | 1.67869849 |
| 31 | MP0002876_abnormal_thyroid_physiology | 1.66837918 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.64608151 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.62642849 |
| 34 | MP0003866_abnormal_defecation | 1.60662408 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.50006531 |
| 36 | MP0005451_abnormal_body_composition | 1.49125546 |
| 37 | MP0001188_hyperpigmentation | 1.47426193 |
| 38 | MP0003806_abnormal_nucleotide_metabolis | 1.44328230 |
| 39 | MP0004270_analgesia | 1.31492663 |
| 40 | MP0002089_abnormal_postnatal_growth/wei | 1.31068490 |
| 41 | MP0001958_emphysema | 1.30895208 |
| 42 | MP0001663_abnormal_digestive_system | 1.23000415 |
| 43 | MP0002796_impaired_skin_barrier | 1.22019490 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.21895443 |
| 45 | MP0000537_abnormal_urethra_morphology | 1.20767450 |
| 46 | MP0003283_abnormal_digestive_organ | 1.20296579 |
| 47 | MP0005381_digestive/alimentary_phenotyp | 1.16019105 |
| 48 | MP0005319_abnormal_enzyme/_coenzyme | 1.15574033 |
| 49 | MP0001664_abnormal_digestion | 1.15441629 |
| 50 | MP0002118_abnormal_lipid_homeostasis | 1.13234130 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.10768298 |
| 52 | MP0004885_abnormal_endolymph | 1.10407389 |
| 53 | * MP0000538_abnormal_urinary_bladder | 1.09027587 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.07991597 |
| 55 | MP0000477_abnormal_intestine_morphology | 0.99556176 |
| 56 | MP0003705_abnormal_hypodermis_morpholog | 0.98509764 |
| 57 | MP0004782_abnormal_surfactant_physiolog | 0.97811527 |
| 58 | MP0001764_abnormal_homeostasis | 0.96038236 |
| 59 | MP0010155_abnormal_intestine_physiology | 0.95566620 |
| 60 | MP0000230_abnormal_systemic_arterial | 0.95173986 |
| 61 | MP0000609_abnormal_liver_physiology | 0.94800392 |
| 62 | MP0002822_catalepsy | 0.90570934 |
| 63 | MP0005501_abnormal_skin_physiology | 0.85485042 |
| 64 | MP0005174_abnormal_tail_pigmentation | 0.83982323 |
| 65 | MP0001873_stomach_inflammation | 0.82122830 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 0.80516715 |
| 67 | MP0009785_altered_susceptibility_to | 0.80091575 |
| 68 | MP0003638_abnormal_response/metabolism_ | 0.79807338 |
| 69 | * MP0001845_abnormal_inflammatory_respons | 0.79592440 |
| 70 | MP0005666_abnormal_adipose_tissue | 0.78834520 |
| 71 | MP0009115_abnormal_fat_cell | 0.77870817 |
| 72 | MP0000490_abnormal_crypts_of | 0.76575131 |
| 73 | MP0005448_abnormal_energy_balance | 0.75425589 |
| 74 | * MP0009642_abnormal_blood_homeostasis | 0.74867495 |
| 75 | MP0003315_abnormal_perineum_morphology | 0.71110022 |
| 76 | MP0003186_abnormal_redox_activity | 0.70452108 |
| 77 | MP0002098_abnormal_vibrissa_morphology | 0.70283943 |
| 78 | MP0006054_spinal_hemorrhage | 0.70193618 |
| 79 | MP0003724_increased_susceptibility_to | 0.69241062 |
| 80 | MP0000427_abnormal_hair_cycle | 0.67280601 |
| 81 | MP0003879_abnormal_hair_cell | 0.66865894 |
| 82 | * MP0002135_abnormal_kidney_morphology | 0.65763614 |
| 83 | MP0004858_abnormal_nervous_system | 0.64769124 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.63751337 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 0.63711264 |
| 86 | MP0006036_abnormal_mitochondrial_physio | 0.63263083 |
| 87 | MP0005645_abnormal_hypothalamus_physiol | 0.60545007 |
| 88 | MP0005535_abnormal_body_temperature | 0.60140081 |
| 89 | MP0002896_abnormal_bone_mineralization | 0.59928747 |
| 90 | MP0000678_abnormal_parathyroid_gland | 0.59665610 |
| 91 | MP0005671_abnormal_response_to | 0.57911616 |
| 92 | MP0002254_reproductive_system_inflammat | 0.57545505 |
| 93 | MP0001849_ear_inflammation | 0.57092345 |
| 94 | MP0005334_abnormal_fat_pad | 0.56726170 |
| 95 | MP0000249_abnormal_blood_vessel | 0.56687623 |
| 96 | MP0003718_maternal_effect | 0.56179758 |
| 97 | MP0008872_abnormal_physiological_respon | 0.54480156 |
| 98 | MP0005266_abnormal_metabolism | 0.53975795 |
| 99 | MP0001986_abnormal_taste_sensitivity | 0.52181490 |
| 100 | MP0002069_abnormal_eating/drinking_beha | 0.51682103 |
| 101 | MP0000604_amyloidosis | 0.51020980 |
| 102 | MP0009764_decreased_sensitivity_to | 0.50348139 |
| 103 | MP0005166_decreased_susceptibility_to | 0.49770847 |
| 104 | MP0001835_abnormal_antigen_presentation | 0.48895310 |
| 105 | MP0008775_abnormal_heart_ventricle | 0.48836600 |
| 106 | MP0009780_abnormal_chondrocyte_physiolo | 0.47950532 |
| 107 | MP0000465_gastrointestinal_hemorrhage | 0.47377166 |
| 108 | MP0000598_abnormal_liver_morphology | 0.47186127 |
| 109 | MP0005025_abnormal_response_to | 0.47140217 |
| 110 | MP0005395_other_phenotype | 0.47109228 |
| 111 | MP0005387_immune_system_phenotype | 0.46169468 |
| 112 | MP0001790_abnormal_immune_system | 0.46169468 |
| 113 | MP0004484_altered_response_of | 0.46159093 |
| 114 | MP0008469_abnormal_protein_level | 0.44864616 |
| 115 | MP0000467_abnormal_esophagus_morphology | 0.44796511 |
| 116 | MP0002078_abnormal_glucose_homeostasis | 0.44190940 |
| 117 | MP0003953_abnormal_hormone_level | 0.43789937 |
| 118 | MP0005376_homeostasis/metabolism_phenot | 0.43579074 |
| 119 | MP0002166_altered_tumor_susceptibility | 0.43330194 |
| 120 | MP0005367_renal/urinary_system_phenotyp | 0.43252204 |
| 121 | MP0000516_abnormal_urinary_system | 0.43252204 |
| 122 | MP0006082_CNS_inflammation | 0.43188688 |
| 123 | MP0002148_abnormal_hypersensitivity_rea | 0.42304900 |
| 124 | MP0005165_increased_susceptibility_to | 0.40897463 |
| 125 | MP0001216_abnormal_epidermal_layer | 0.40131344 |
| 126 | MP0001485_abnormal_pinna_reflex | 0.39974572 |
| 127 | MP0005551_abnormal_eye_electrophysiolog | 0.39536781 |
| 128 | MP0002168_other_aberrant_phenotype | 0.39160084 |
| 129 | MP0005310_abnormal_salivary_gland | 0.38944171 |
| 130 | MP0005670_abnormal_white_adipose | 0.38781243 |
| 131 | MP0009697_abnormal_copulation | 0.38712789 |
| 132 | MP0005408_hypopigmentation | 0.38646207 |
| 133 | MP0005410_abnormal_fertilization | 0.38456897 |
| 134 | MP0009053_abnormal_anal_canal | 0.37988181 |
| 135 | MP0001191_abnormal_skin_condition | 0.37356988 |
| 136 | MP0002971_abnormal_brown_adipose | 0.36146081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 6.32009143 |
| 2 | Metabolic alkalosis (HP:0200114) | 6.29995932 |
| 3 | Hyperactive renin-angiotensin system (HP:0000841) | 6.18328003 |
| 4 | Hypokalemic alkalosis (HP:0001949) | 5.78163656 |
| 5 | Abnormality of chloride homeostasis (HP:0011422) | 5.62406458 |
| 6 | Hyperglycinuria (HP:0003108) | 5.47556355 |
| 7 | * Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.44712725 |
| 8 | Hypomagnesemia (HP:0002917) | 5.44415697 |
| 9 | Gout (HP:0001997) | 5.35721086 |
| 10 | Abnormal urine output (HP:0012590) | 5.28763432 |
| 11 | Polyuria (HP:0000103) | 5.09626441 |
| 12 | Abnormality of magnesium homeostasis (HP:0004921) | 5.07780308 |
| 13 | Hydroxyprolinuria (HP:0003080) | 5.06521606 |
| 14 | Abnormality of proline metabolism (HP:0010907) | 5.06521606 |
| 15 | Proximal tubulopathy (HP:0000114) | 5.00187011 |
| 16 | Abnormality of renal excretion (HP:0011036) | 4.99278557 |
| 17 | Abnormality of purine metabolism (HP:0004352) | 4.41052505 |
| 18 | Hyperuricemia (HP:0002149) | 4.27981220 |
| 19 | Increased purine levels (HP:0004368) | 4.27981220 |
| 20 | Glycosuria (HP:0003076) | 4.22985766 |
| 21 | Abnormality of urine glucose concentration (HP:0011016) | 4.22985766 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 4.22004930 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.22004930 |
| 24 | Malnutrition (HP:0004395) | 4.16131670 |
| 25 | Ileus (HP:0002595) | 4.12563550 |
| 26 | Abnormality of renin-angiotensin system (HP:0000847) | 4.04424951 |
| 27 | Alkalosis (HP:0001948) | 4.01180932 |
| 28 | Abnormal drinking behavior (HP:0030082) | 3.96739316 |
| 29 | Polydipsia (HP:0001959) | 3.96739316 |
| 30 | Hyperaldosteronism (HP:0000859) | 3.94861577 |
| 31 | Tetany (HP:0001281) | 3.88534579 |
| 32 | Renal salt wasting (HP:0000127) | 3.69776146 |
| 33 | Decreased circulating renin level (HP:0003351) | 3.68384521 |
| 34 | Systemic lupus erythematosus (HP:0002725) | 3.67641707 |
| 35 | Hypercalciuria (HP:0002150) | 3.66964265 |
| 36 | Congenital sensorineural hearing impairment (HP:0008527) | 3.59099862 |
| 37 | Hyperphosphaturia (HP:0003109) | 3.48039261 |
| 38 | Widely patent fontanelles and sutures (HP:0004492) | 3.44057385 |
| 39 | Generalized aminoaciduria (HP:0002909) | 3.39108690 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.34764786 |
| 41 | Ketoacidosis (HP:0001993) | 3.27474216 |
| 42 | Autoimmune thrombocytopenia (HP:0001973) | 3.27401596 |
| 43 | Abnormal urine phosphate concentration (HP:0012599) | 3.22098569 |
| 44 | Dehydration (HP:0001944) | 3.15223682 |
| 45 | Confusion (HP:0001289) | 3.14902627 |
| 46 | Hypokalemia (HP:0002900) | 3.09716799 |
| 47 | Steatorrhea (HP:0002570) | 3.00642881 |
| 48 | Posterior subcapsular cataract (HP:0007787) | 3.00029441 |
| 49 | Delayed epiphyseal ossification (HP:0002663) | 2.97123478 |
| 50 | * Nephrolithiasis (HP:0000787) | 2.96931710 |
| 51 | Renal tubular acidosis (HP:0001947) | 2.96817045 |
| 52 | Hypolipoproteinemia (HP:0010981) | 2.94370992 |
| 53 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.89438217 |
| 54 | Facial shape deformation (HP:0011334) | 2.80823693 |
| 55 | Potter facies (HP:0002009) | 2.80823693 |
| 56 | Hypophosphatemia (HP:0002148) | 2.72090339 |
| 57 | Abnormality of vitamin B metabolism (HP:0004340) | 2.68555867 |
| 58 | Acanthocytosis (HP:0001927) | 2.65720155 |
| 59 | Epidermoid cyst (HP:0200040) | 2.65588951 |
| 60 | Hypobetalipoproteinemia (HP:0003563) | 2.64579806 |
| 61 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.63995569 |
| 62 | Ketosis (HP:0001946) | 2.61230449 |
| 63 | Metabolic acidosis (HP:0001942) | 2.59180266 |
| 64 | Hyperammonemia (HP:0001987) | 2.54049488 |
| 65 | Abnormality of potassium homeostasis (HP:0011042) | 2.51380363 |
| 66 | Conjugated hyperbilirubinemia (HP:0002908) | 2.46342900 |
| 67 | Thin bony cortex (HP:0002753) | 2.44059644 |
| 68 | Vascular calcification (HP:0004934) | 2.35275401 |
| 69 | Pancreatitis (HP:0001733) | 2.33456171 |
| 70 | Rickets (HP:0002748) | 2.32135208 |
| 71 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.30717672 |
| 72 | Fat malabsorption (HP:0002630) | 2.25286961 |
| 73 | Metaphyseal cupping (HP:0003021) | 2.24870589 |
| 74 | Nephrocalcinosis (HP:0000121) | 2.24504304 |
| 75 | Nausea (HP:0002018) | 2.23647424 |
| 76 | Focal segmental glomerulosclerosis (HP:0000097) | 2.23591775 |
| 77 | Xanthomatosis (HP:0000991) | 2.22005830 |
| 78 | Megaloblastic anemia (HP:0001889) | 2.21955273 |
| 79 | Abnormal tarsal ossification (HP:0008369) | 2.20066096 |
| 80 | Hypoalbuminemia (HP:0003073) | 2.19370029 |
| 81 | Abnormal albumin level (HP:0012116) | 2.19370029 |
| 82 | Chronic diarrhea (HP:0002028) | 2.18125565 |
| 83 | Cerebral palsy (HP:0100021) | 2.18046606 |
| 84 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.14863284 |
| 85 | Wide cranial sutures (HP:0010537) | 2.13909642 |
| 86 | Vomiting (HP:0002013) | 2.13628382 |
| 87 | Cupped ribs (HP:0000887) | 2.11172608 |
| 88 | Poikilocytosis (HP:0004447) | 2.09023334 |
| 89 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.08886880 |
| 90 | Villous atrophy (HP:0011473) | 2.08886880 |
| 91 | Irritability (HP:0000737) | 2.08711473 |
| 92 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.08641628 |
| 93 | Dicarboxylic aciduria (HP:0003215) | 2.08641628 |
| 94 | Abnormality of vitamin metabolism (HP:0100508) | 2.08155067 |
| 95 | Cardiovascular calcification (HP:0011915) | 2.07675151 |
| 96 | Hyperglycinemia (HP:0002154) | 2.06692740 |
| 97 | Vacuolated lymphocytes (HP:0001922) | 2.06581653 |
| 98 | Glomerulonephritis (HP:0000099) | 2.05651829 |
| 99 | Abdominal distention (HP:0003270) | 2.05281907 |
| 100 | Abnormality of sodium homeostasis (HP:0010931) | 2.00894508 |
| 101 | Hyponatremia (HP:0002902) | 1.99622435 |
| 102 | Chorioretinal atrophy (HP:0000533) | 1.99522470 |
| 103 | Hyperventilation (HP:0002883) | 1.95566667 |
| 104 | Delayed CNS myelination (HP:0002188) | 1.95469708 |
| 105 | Protuberant abdomen (HP:0001538) | 1.95397611 |
| 106 | Adrenal overactivity (HP:0002717) | 1.93926161 |
| 107 | Abnormal glucose tolerance (HP:0001952) | 1.93248570 |
| 108 | Hyperphosphatemia (HP:0002905) | 1.91920601 |
| 109 | Hyperparathyroidism (HP:0000843) | 1.91885114 |
| 110 | Right ventricular cardiomyopathy (HP:0011663) | 1.91266306 |
| 111 | Renal tubular dysfunction (HP:0000124) | 1.91036882 |
| 112 | Hypophosphatemic rickets (HP:0004912) | 1.90185123 |
| 113 | Complement deficiency (HP:0004431) | 1.87727323 |
| 114 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.87452664 |
| 115 | Hypotension (HP:0002615) | 1.87356716 |
| 116 | Lethargy (HP:0001254) | 1.87012437 |
| 117 | Subcapsular cataract (HP:0000523) | 1.86818797 |
| 118 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.86579686 |
| 119 | * Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.86413661 |
| 120 | Autoimmune hemolytic anemia (HP:0001890) | 1.85267759 |
| 121 | Hemorrhage of the eye (HP:0011885) | 1.85191293 |
| 122 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.82803821 |
| 123 | Methylmalonic aciduria (HP:0012120) | 1.82156282 |
| 124 | Abnormality of the costochondral junction (HP:0000919) | 1.81241254 |
| 125 | Nephritis (HP:0000123) | 1.79145652 |
| 126 | Abnormality of carpal bone ossification (HP:0006257) | 1.77744940 |
| 127 | Pigmentary retinal degeneration (HP:0001146) | 1.77432561 |
| 128 | Metaphyseal irregularity (HP:0003025) | 1.74910061 |
| 129 | Hypothermia (HP:0002045) | 1.73248969 |
| 130 | Chondrocalcinosis (HP:0000934) | 1.72829675 |
| 131 | Enlarged epiphyses (HP:0010580) | 1.72561803 |
| 132 | Late onset (HP:0003584) | 1.72499262 |
| 133 | Intrahepatic cholestasis (HP:0001406) | 1.71167014 |
| 134 | Glomerulosclerosis (HP:0000096) | 1.69281792 |
| 135 | Abnormality of complement system (HP:0005339) | 1.64149223 |
| 136 | Abnormal biliary tract morphology (HP:0012440) | 1.63460998 |
| 137 | Hypocalcemia (HP:0002901) | 1.63157557 |
| 138 | Patchy hypopigmentation of hair (HP:0011365) | 1.58642982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 9.36253596 |
| 2 | WNK4 | 6.70757803 |
| 3 | WNK3 | 6.19048981 |
| 4 | OXSR1 | 5.80484547 |
| 5 | MST4 | 4.23343187 |
| 6 | FRK | 4.00897999 |
| 7 | MST1R | 3.41214113 |
| 8 | STK39 | 3.27429756 |
| 9 | GRK6 | 2.63021272 |
| 10 | LMTK2 | 2.36599073 |
| 11 | NME1 | 2.09946013 |
| 12 | TNIK | 1.96223001 |
| 13 | STK38L | 1.85666502 |
| 14 | PRKG2 | 1.71458064 |
| 15 | CASK | 1.71217952 |
| 16 | RIPK1 | 1.69524236 |
| 17 | EPHA4 | 1.68255868 |
| 18 | PTK6 | 1.57726369 |
| 19 | NEK1 | 1.53995783 |
| 20 | PDK3 | 1.51418978 |
| 21 | PDK4 | 1.51418978 |
| 22 | BCKDK | 1.49990058 |
| 23 | AKT3 | 1.44532180 |
| 24 | ADRBK2 | 1.44094647 |
| 25 | ERN1 | 1.43419097 |
| 26 | BMPR1B | 1.41917733 |
| 27 | MAP3K2 | 1.39585080 |
| 28 | PDK2 | 1.37016433 |
| 29 | STK24 | 1.35909820 |
| 30 | MAP3K12 | 1.33118963 |
| 31 | MAP2K2 | 1.31227042 |
| 32 | EPHA2 | 1.30085051 |
| 33 | MET | 1.21679809 |
| 34 | MAP3K10 | 1.21332358 |
| 35 | EPHA3 | 1.17084647 |
| 36 | WNK1 | 1.16574045 |
| 37 | STK10 | 1.15900700 |
| 38 | MAP4K2 | 1.13868609 |
| 39 | EPHB2 | 1.09358617 |
| 40 | TXK | 1.05760093 |
| 41 | DAPK2 | 1.04828678 |
| 42 | LRRK2 | 1.02229481 |
| 43 | EPHB1 | 0.99717700 |
| 44 | PRKCI | 0.99635385 |
| 45 | PTK2 | 0.96715919 |
| 46 | IRAK1 | 0.95855497 |
| 47 | TLK1 | 0.95162070 |
| 48 | SGK494 | 0.94511921 |
| 49 | SGK223 | 0.94511921 |
| 50 | NLK | 0.92479696 |
| 51 | PINK1 | 0.89061610 |
| 52 | PAK4 | 0.87179327 |
| 53 | MAP3K7 | 0.86026460 |
| 54 | MAP3K3 | 0.85470286 |
| 55 | TESK2 | 0.82904186 |
| 56 | TAOK1 | 0.80397627 |
| 57 | LATS1 | 0.75727895 |
| 58 | TTK | 0.74972075 |
| 59 | MAPK11 | 0.73496388 |
| 60 | FER | 0.72736351 |
| 61 | MAP3K11 | 0.72087221 |
| 62 | TESK1 | 0.71688873 |
| 63 | STK38 | 0.71159790 |
| 64 | TEC | 0.69134931 |
| 65 | MAPKAPK3 | 0.69014220 |
| 66 | PRKAA2 | 0.65012522 |
| 67 | FGFR4 | 0.64862265 |
| 68 | SGK3 | 0.61427549 |
| 69 | MAP2K6 | 0.59697421 |
| 70 | MYLK | 0.59482948 |
| 71 | FGFR3 | 0.59433190 |
| 72 | BMX | 0.58664197 |
| 73 | NUAK1 | 0.58343042 |
| 74 | PRKAA1 | 0.57731548 |
| 75 | SCYL2 | 0.57490400 |
| 76 | PDPK1 | 0.57279365 |
| 77 | MAP3K8 | 0.54913049 |
| 78 | GSK3A | 0.54278629 |
| 79 | CAMK2D | 0.52217246 |
| 80 | DYRK1B | 0.52021213 |
| 81 | IKBKE | 0.50460539 |
| 82 | BMPR2 | 0.49510052 |
| 83 | KSR2 | 0.49203801 |
| 84 | DDR2 | 0.47251645 |
| 85 | CAMK2A | 0.46007884 |
| 86 | PRKACA | 0.45475866 |
| 87 | CDC42BPA | 0.43306405 |
| 88 | ERBB2 | 0.43259644 |
| 89 | MAPK13 | 0.42491176 |
| 90 | MATK | 0.41741457 |
| 91 | PAK3 | 0.40846179 |
| 92 | SYK | 0.39749724 |
| 93 | IGF1R | 0.38955587 |
| 94 | CSF1R | 0.38723162 |
| 95 | MAP2K1 | 0.38036060 |
| 96 | IRAK3 | 0.37245912 |
| 97 | PRKCE | 0.36634537 |
| 98 | NEK6 | 0.36381690 |
| 99 | PDK1 | 0.35570718 |
| 100 | ERBB4 | 0.35469960 |
| 101 | PRKG1 | 0.34611453 |
| 102 | PIK3CG | 0.33358776 |
| 103 | ERBB3 | 0.32918307 |
| 104 | SGK2 | 0.32316076 |
| 105 | PBK | 0.30662248 |
| 106 | RIPK4 | 0.30659189 |
| 107 | ADRBK1 | 0.30494568 |
| 108 | LYN | 0.30464326 |
| 109 | AKT2 | 0.29758227 |
| 110 | CAMK2B | 0.28232094 |
| 111 | LCK | 0.27439793 |
| 112 | PRKCD | 0.27399991 |
| 113 | KIT | 0.26341630 |
| 114 | IKBKB | 0.26070554 |
| 115 | PRKCA | 0.25879031 |
| 116 | CAMK2G | 0.25356760 |
| 117 | FYN | 0.25325436 |
| 118 | SGK1 | 0.24761928 |
| 119 | MAP3K14 | 0.24178263 |
| 120 | BCR | 0.23778150 |
| 121 | MAP3K1 | 0.23751298 |
| 122 | PRKACG | 0.23120523 |
| 123 | STK11 | 0.20565543 |
| 124 | PRKCZ | 0.20103825 |
| 125 | SRC | 0.17069105 |
| 126 | INSRR | 0.16875863 |
| 127 | PIM1 | 0.15758377 |
| 128 | CSK | 0.15549839 |
| 129 | ABL2 | 0.15240038 |
| 130 | CSNK1A1 | 0.13163170 |
| 131 | TBK1 | 0.12634398 |
| 132 | ROCK1 | 0.12544883 |
| 133 | STK3 | 0.11838050 |
| 134 | TIE1 | 0.10042112 |
| 135 | PRKCQ | 0.08006059 |
| 136 | ITK | 0.07206793 |
| 137 | JAK2 | 0.06959999 |
| 138 | ICK | 0.06461183 |
| 139 | MAP4K1 | 0.06373968 |
| 140 | GRK1 | 0.06363587 |
| 141 | TAOK3 | 0.05972498 |
| 142 | PRKD2 | 0.05761052 |
| 143 | PIK3CA | 0.05135007 |
| 144 | TYK2 | 0.04815083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.94729699 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.57357934 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 3.28248655 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.25035620 |
| 5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.12466607 |
| 6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.06981075 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.92713404 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.41611095 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.38327459 |
| 10 | Bile secretion_Homo sapiens_hsa04976 | 2.34032299 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27896909 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.21020290 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.14262534 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.11312461 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.07893291 |
| 16 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.05150537 |
| 17 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 2.01812103 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.01380401 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.98723162 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.98440790 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.91716110 |
| 22 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.90206279 |
| 23 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.84325944 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.81497664 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.77523149 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.72223140 |
| 27 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.64299776 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59014976 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.58950234 |
| 30 | Galactose metabolism_Homo sapiens_hsa00052 | 1.57721272 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.57104653 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.42524716 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.40164969 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.39414920 |
| 35 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.38256916 |
| 36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.37207117 |
| 37 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.36440102 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.33322067 |
| 39 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.30511472 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.29858707 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.21674256 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.20561374 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.14171915 |
| 44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13622970 |
| 45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.10881476 |
| 46 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.09962999 |
| 47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.06916826 |
| 48 | Asthma_Homo sapiens_hsa05310 | 1.04068205 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.03136008 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03118332 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92532884 |
| 52 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.87650256 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 0.86836537 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82699735 |
| 55 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.78860109 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.78329373 |
| 57 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78117664 |
| 58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74615205 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74103741 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73982690 |
| 61 | Allograft rejection_Homo sapiens_hsa05330 | 0.73186045 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72936535 |
| 63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.72879782 |
| 64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69136484 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68930258 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.68153974 |
| 67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67416140 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65530381 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.62747484 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60291832 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56228134 |
| 72 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.54657592 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54315687 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53975995 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53864758 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50865241 |
| 77 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.47754044 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46926554 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46519725 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45830584 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43586544 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.42815570 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40254299 |
| 84 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38128671 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.33153194 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.32756157 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.32736717 |
| 88 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.31997115 |
| 89 | Tight junction_Homo sapiens_hsa04530 | 0.31394145 |
| 90 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.30665478 |
| 91 | Insulin secretion_Homo sapiens_hsa04911 | 0.29488278 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29374038 |
| 93 | Cocaine addiction_Homo sapiens_hsa05030 | 0.26495062 |
| 94 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.23945555 |
| 95 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.21424764 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19491163 |
| 97 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.19343053 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17756279 |
| 99 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.16806841 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.16700867 |
| 101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.16274988 |
| 102 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14675122 |
| 103 | Parkinsons disease_Homo sapiens_hsa05012 | 0.14634215 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.14439188 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.13759160 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.13341575 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13020802 |
| 108 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.12855726 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.12067753 |
| 110 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.06580840 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.06545750 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.06257727 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.05946277 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.05735286 |
| 115 | Alzheimers disease_Homo sapiens_hsa05010 | 0.05068230 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.04158646 |
| 117 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.03715085 |
| 118 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.02851614 |
| 119 | Sulfur relay system_Homo sapiens_hsa04122 | 0.01103522 |
| 120 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.01054020 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0719181 |
| 122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0617516 |
| 123 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0194145 |
| 124 | Pertussis_Homo sapiens_hsa05133 | -0.0166572 |
| 125 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0151412 |
| 126 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | -0.0118913 |

